[Corrigendum] 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5.

Following the publication of the above article and a corrigendum (doi: 10.3892/or.2022.8264) that was published 3 years ago to resolve the issue of two sets of duplicated western blots in Fig. 3, an interested reader drew to the authors' attention that, in Fig. 5b on p. 2441, the western blot data bands shown to represent the GRP78 and Bcl‑2 proteins in the MCF‑7 group were strikingly similar; furthermore, the β‑actin bands shown for the MDA‑MB‑231 group in Fig. 5c were strikingly similar to the β‑actin bands shown in Fig. 2c on p. 2439. After having re‑examined their original data, the authors realized that the figure parts in question were inadvertently assembled erroneously. The revised version of Fig. 5, now featuring the correct data for the GRP78 western blot bands for the MCF‑7 group in Fig. 5b and the β‑actin bands in Fig. 5c, is shown in the next page. Note that the errors made in assembling this figure did not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of for granting them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused. [Oncology Reports 40: 2435‑2444, 2018; DOI: 10.3892/or.2018.6644].